117 related articles for article (PubMed ID: 8819344)
1. Application of a biologically-based RFD estimation method to tetrachlorodibenzo-p-dioxin (TCDD) mediated immune suppression and enzyme induction.
McGrath LF; Georgopoulos P; Gallo MA
Risk Anal; 1996 Aug; 16(4):539-48. PubMed ID: 8819344
[TBL] [Abstract][Full Text] [Related]
2. Potentiation and antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin effects in a complex environmental mixture.
Silkworth JB; Cutler DS; O'Keefe PW; Lipinskas T
Toxicol Appl Pharmacol; 1993 Apr; 119(2):236-47. PubMed ID: 8480332
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
Gaylor DW; Aylward LL
Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
[TBL] [Abstract][Full Text] [Related]
4. Alternative models for low dose-response analysis of biochemical and immunological endpoints for tetrachlorodibenzo-p-dioxin.
McGrath LF; Cooper KR; Georgopoulos P; Gallo MA
Regul Toxicol Pharmacol; 1995 Jun; 21(3):382-96. PubMed ID: 7480892
[TBL] [Abstract][Full Text] [Related]
5. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
[TBL] [Abstract][Full Text] [Related]
6. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics.
Simon T; Aylward LL; Kirman CR; Rowlands JC; Budinsky RA
Toxicol Sci; 2009 Dec; 112(2):490-506. PubMed ID: 19776211
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Kerkvliet NI; Brauner JA
Environ Res; 1990 Aug; 52(2):146-54. PubMed ID: 2118453
[TBL] [Abstract][Full Text] [Related]
8. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies.
Greene JF; Hays S; Paustenbach D
J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432
[TBL] [Abstract][Full Text] [Related]
9. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
12. Use of a toxicokinetic model in the analysis of cancer mortality in relation to the estimated absorbed dose of dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD).
Salvan A; Thomaseth K; Bortot P; Sartori N
Sci Total Environ; 2001 Jul; 274(1-3):21-35. PubMed ID: 11453298
[TBL] [Abstract][Full Text] [Related]
13. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
14. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR.
Connor KT; Aylward LL
J Toxicol Environ Health B Crit Rev; 2006; 9(2):147-71. PubMed ID: 16613807
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice.
Burleson GR; Lebrec H; Yang YG; Ibanes JD; Pennington KN; Birnbaum LS
Fundam Appl Toxicol; 1996 Jan; 29(1):40-7. PubMed ID: 8838638
[TBL] [Abstract][Full Text] [Related]
16. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
Shen ES; Guengerich FP; Olson JR
Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
[TBL] [Abstract][Full Text] [Related]
17. Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination.
Aylward LL; Brunet RC; Starr TB; Carrier G; Delzell E; Cheng H; Beall C
Risk Anal; 2005 Aug; 25(4):945-56. PubMed ID: 16268942
[TBL] [Abstract][Full Text] [Related]
18. The effects of perinatal exposure to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune organs in rats.
Nohara K; Fujimaki H; Tsukumo S; Ushio H; Miyabara Y; Kijima M; Tohyama C; Yonemoto J
Toxicology; 2000 Nov; 154(1-3):123-33. PubMed ID: 11118676
[TBL] [Abstract][Full Text] [Related]
19. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of dioxin toxicity: relationship to risk assessment.
Birnbaum LS
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):157-67. PubMed ID: 7698077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
